About triptoreli n
Gonadotropin-releasing hormone agonist
Used for
- Prostate cancer
- Endometriosis
- Uterine fibroids before surgery
- Central precocious puberty
Usual adult dose
Usually 3.75 mg intramuscularly every 4 weeks for prostate cancer, endometriosis, or fibroids; schedules vary by indication.
Usual dose in children
For central precocious puberty, usually 3.75 mg intramuscularly every 4 weeks; specialist dosing may vary.
Common side effects
- Hot flashes and sweating
- Headache
- Reduced libido
- Injection-site pain
Important warnings
- May initially worsen prostate cancer symptoms; short-term additional treatment may be needed.
- Can reduce bone density, especially with prolonged treatment.
- May cause mood changes, high blood sugar, or heart rhythm problems.
- Not suitable during pregnancy; discuss reliable contraception during treatment.
Pregnancy
Avoid during pregnancy. It may harm fetal development; pregnancy should be excluded before treatment.
Breastfeeding
Not recommended during breastfeeding.
Interactions
- Medicines that prolong the QT interval may increase heart rhythm risks.
- Other hormone treatments may alter effects; clinicians should review concurrent medicines.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.